Format

Send to:

Choose Destination

Decreased pre-bronchodilator forced expiratory flow 25-75%

MedGen UID:
1688020
•Concept ID:
C5139293
•
Finding
Synonyms: Decreased pre bronchodilator forced expiratory flow 25-75%; Decreased pre-bronchodilator FEF25-75%; Decreased prebronchodilator forced expiratory flow 25-75%
 
HPO: HP:0032360

Definition

A reduction compared to the predicted value of the forced expiratory flow over the middle one-half of the FVC; the average flow from the point at which 25% of the FVC has been exhaled to the point at which 75% of the FVC has been exhaled. Here, the test is performed before the administration of a bronchodilating medication. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVDecreased pre-bronchodilator forced expiratory flow 25-75%

Recent clinical studies

Etiology

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma.
Pelaia C, Busceti MT, Crimi C, Carpagnano GE, Lombardo N, Terracciano R, Vatrella A, Pelaia G
Biomed Pharmacother 2020 Sep;129:110444. Epub 2020 Jun 24 doi: 10.1016/j.biopha.2020.110444. PMID: 32593131

Diagnosis

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma.
Pelaia C, Busceti MT, Crimi C, Carpagnano GE, Lombardo N, Terracciano R, Vatrella A, Pelaia G
Biomed Pharmacother 2020 Sep;129:110444. Epub 2020 Jun 24 doi: 10.1016/j.biopha.2020.110444. PMID: 32593131

Therapy

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma.
Pelaia C, Busceti MT, Crimi C, Carpagnano GE, Lombardo N, Terracciano R, Vatrella A, Pelaia G
Biomed Pharmacother 2020 Sep;129:110444. Epub 2020 Jun 24 doi: 10.1016/j.biopha.2020.110444. PMID: 32593131

Clinical prediction guides

Real-Life effects of benralizumab on exacerbation number and lung hyperinflation in atopic patients with severe eosinophilic asthma.
Pelaia C, Busceti MT, Crimi C, Carpagnano GE, Lombardo N, Terracciano R, Vatrella A, Pelaia G
Biomed Pharmacother 2020 Sep;129:110444. Epub 2020 Jun 24 doi: 10.1016/j.biopha.2020.110444. PMID: 32593131

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Reviews

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...